Historically, ransomware tactics were primarily centered around encrypting victim data and demanding payment for decryption ...
Global biopharma leader CSL today announced five-year (60-month) results from the pivotal Phase 3 HOPE-B study, confirming the long-term durability and safety of a one-time infusion of HEMGENIX® ...
The event included the opening keynote by AWS CEO Matt Garman before a more AI-focused talk from Dr. Swami Sivasubramanian, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results